Drug diversions are not only a regulatory issue, they can also lead to patient safety issues. Most diversions happen with controlled substances, but did you know there are risks and liabilities beyond your narcotic box? Proper medication management is critical from both a regulatory and clinical standpoint. Do you know what steps to take to maintain regulatory compliance and to keep your staff and patients safe?
Get your new DEA-222 forms before October 30, 2021. The old DEA-222 form will no longer be used after this date. Don’t wait until the last minute to get yours. Delays could happen for a variety of reasons, leaving you without the ability to order certain controlled substances. If you haven’t already done so, act now to avoid alterations or interruptions in patient care.
Opioid misuse remains a priority and an area of focus for the OctariusRx team. A recent report from the Kaiser Family Foundation ranked states by the number of people age 12 or older who reported opioid misuse. There are many variables that lead to inappropriate use. Do you know where your state ranks? Do you know what steps to take to minimize the risk? In this post we will discuss some steps you can take to make your patients safer and reduce your liability.
April 24, 2021 is DEA National Prescription Drug Takeback Day and at OctariusRx we recognize and support the DEA’s efforts to provide education on the potential for abuse of medications. According to the DEA, in addition to education, Takeback Day is an opportunity to provide a safe, convenient, and responsible means of disposing of prescription drugs.
As we approach 2020, we take a few moments to look back at some of the biggest stories of the current year. Each year is extremely busy, and 2019 was no exception. Below we discuss some of the most popular topics of the year. How did we determine popularity? Simple…we decided to focus on the topics that generated the most questions.
Are you currently using DEA-222 forms? The DEA just released a new regulation updating the forms and it goes into effect October 30, 2019. How will this impact your current practice? What changes do you need to make to maintain compliance? Work with your consultant pharmacist to ensure a smooth transition.
